Why is Qingdao Vland Biotech Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 9.05% and Operating profit at 7.40% over the last 5 years
2
The company has declared Negative results for the last 3 consecutive quarters
- ROCE(HY) Lowest at 3.43%
- INTEREST COVERAGE RATIO(Q) Lowest at 539.06
- OPERATING PROFIT(Q) Lowest at CNY 23.08 MM
3
With ROE of 4.90%, it has a expensive valuation with a 1.70 Price to Book Value
- Over the past year, while the stock has generated a return of 4.10%, its profits have fallen by -13.3%
- At the current price, the company has a high dividend yield of 0.7
4
Underperformed the market in the last 1 year
- The stock has generated a return of 4.10% in the last 1 year, much lower than market (China Shanghai Composite) returns of 14.77%
How much should you hold?
- Overall Portfolio exposure to Qingdao Vland Biotech Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Qingdao Vland Biotech Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Qingdao Vland Biotech Co., Ltd.
-100.0%
0.21
37.96%
China Shanghai Composite
15.19%
1.01
14.58%
Quality key factors
Factor
Value
Sales Growth (5y)
9.05%
EBIT Growth (5y)
7.40%
EBIT to Interest (avg)
20.12
Debt to EBITDA (avg)
0.74
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.51
Tax Ratio
25.12%
Dividend Payout Ratio
40.39%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.16%
ROE (avg)
7.19%
Valuation Key Factors 
Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
1.70
EV to EBIT
29.57
EV to EBITDA
14.90
EV to Capital Employed
1.60
EV to Sales
2.41
PEG Ratio
NA
Dividend Yield
0.73%
ROCE (Latest)
5.40%
ROE (Latest)
4.90%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Technical Movement
4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 232.86 MM
RAW MATERIAL COST(Y)
Fallen by -11.65% (YoY
-12What is not working for the Company
ROCE(HY)
Lowest at 3.43%
INTEREST COVERAGE RATIO(Q)
Lowest at 539.06
OPERATING PROFIT(Q)
Lowest at CNY 23.08 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 7.52 %
NET PROFIT(Q)
Lowest at CNY 9.58 MM
EPS(Q)
Lowest at CNY 0.04
Here's what is working for Qingdao Vland Biotech Co., Ltd.
Operating Cash Flow
Highest at CNY 232.86 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Raw Material Cost
Fallen by -11.65% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Qingdao Vland Biotech Co., Ltd.
Interest Coverage Ratio
Lowest at 539.06
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit
Lowest at CNY 23.08 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 7.52 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Net Profit
Lowest at CNY 9.58 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY 0.04
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)






